WMS Group LLC bought a new stake in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) during the 4th quarter, Holdings Channel reports. The firm bought 149,855 shares of the company’s stock, valued at approximately $4,255,000. Invesco Nasdaq Biotechnology ETF accounts for about 5.4% of WMS Group LLC’s portfolio, making the stock its 4th largest holding. WMS Group LLC owned 0.06% of Invesco Nasdaq Biotechnology ETF as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. Independent Advisor Alliance acquired a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter worth $653,000. International Assets Investment Management LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at about $41,000. Royal Bank of Canada acquired a new stake in shares of Invesco Nasdaq Biotechnology ETF in the 4th quarter worth approximately $37,000. Advisory Services Network LLC purchased a new stake in Invesco Nasdaq Biotechnology ETF during the third quarter worth $52,000. Finally, Osaic Holdings Inc. grew its holdings in Invesco Nasdaq Biotechnology ETF by 28.4% in the second quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock valued at $101,000 after purchasing an additional 1,052 shares during the last quarter.
Invesco Nasdaq Biotechnology ETF Price Performance
Shares of IBBQ stock opened at $29.98 on Friday. The stock has a market cap of $67.75 million, a P/E ratio of 17.03 and a beta of 0.62. Invesco Nasdaq Biotechnology ETF has a fifty-two week low of $20.67 and a fifty-two week high of $30.50. The business has a fifty day simple moving average of $29.49 and a 200-day simple moving average of $29.14.
Invesco Nasdaq Biotechnology ETF Announces Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Further Reading
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- MarketBeat Week in Review – 06/15 – 06/19
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
Want to see what other hedge funds are holding IBBQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report).
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
